Chandrika Prasad

Array ( [id] => 5771563 [patent_doc_number] => 20050267014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Pharmaceutical composition comprising factor VII polypeptides and tranexamic acid' [patent_app_type] => utility [patent_app_number] => 11/191525 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17588 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20050267014.pdf [firstpage_image] =>[orig_patent_app_number] => 11191525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905595 [patent_doc_number] => 20050100990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Factor VIII compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/968286 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 34520 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100990.pdf [firstpage_image] =>[orig_patent_app_number] => 10968286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 642213 [patent_doc_number] => 07122634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-17 [patent_title] => 'Modified factor VIII' [patent_app_type] => utility [patent_app_number] => 10/938414 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 31174 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/122/07122634.pdf [firstpage_image] =>[orig_patent_app_number] => 10938414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466063 [patent_doc_number] => 20040198660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Tissue factor antagonist and protein C polypeptide compositions' [patent_app_type] => new [patent_app_number] => 10/700778 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18163 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198660.pdf [firstpage_image] =>[orig_patent_app_number] => 10700778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 956149 [patent_doc_number] => 06955899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-18 [patent_title] => 'Adipocyte complement related protein zacrp13' [patent_app_type] => utility [patent_app_number] => 10/688570 [patent_app_country] => US [patent_app_date] => 2003-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39395 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/955/06955899.pdf [firstpage_image] =>[orig_patent_app_number] => 10688570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7281540 [patent_doc_number] => 20040063917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Modified erythropoietin (epo) with reduced immunogenicity' [patent_app_type] => new [patent_app_number] => 10/467115 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11850 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063917.pdf [firstpage_image] =>[orig_patent_app_number] => 10467115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394125 [patent_doc_number] => 20040038352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Method for fermentative production of amino acids and amino acid derivatives of the phosphoglycerate family' [patent_app_type] => new [patent_app_number] => 10/620487 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3888 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038352.pdf [firstpage_image] =>[orig_patent_app_number] => 10620487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7224546 [patent_doc_number] => 20040072755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'TF antagonist' [patent_app_type] => new [patent_app_number] => 10/617500 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19862 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072755.pdf [firstpage_image] =>[orig_patent_app_number] => 10617500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207983 [patent_doc_number] => 20040087643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Method of treating thrombocytopenic purpura and hemolytic uremic syndrome' [patent_app_type] => new [patent_app_number] => 10/602936 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4338 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087643.pdf [firstpage_image] =>[orig_patent_app_number] => 10602936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 493970 [patent_doc_number] => 07211558 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Compositions and methods for the treatment of hemophilia A' [patent_app_type] => utility [patent_app_number] => 10/445235 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8637 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 976 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211558.pdf [firstpage_image] =>[orig_patent_app_number] => 10445235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 690772 [patent_doc_number] => 07074755 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Erythropoietin conjugate compounds with extended half-lives' [patent_app_type] => utility [patent_app_number] => 10/439870 [patent_app_country] => US [patent_app_date] => 2003-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6628 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074755.pdf [firstpage_image] =>[orig_patent_app_number] => 10439870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367253 [patent_doc_number] => 20040006021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Pharmaceutical composition comprising factor Vll polypeptides and tranexamic acid' [patent_app_type] => new [patent_app_number] => 10/437674 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17785 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006021.pdf [firstpage_image] =>[orig_patent_app_number] => 10437674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367250 [patent_doc_number] => 20040006020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Pharmaceutical composition comprising a factor VII polypeptide and epsilon-aminocaproic acid' [patent_app_type] => new [patent_app_number] => 10/437522 [patent_app_country] => US [patent_app_date] => 2003-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17573 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006020.pdf [firstpage_image] =>[orig_patent_app_number] => 10437522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232722 [patent_doc_number] => 20050256035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Ctp-extended erythropoietin' [patent_app_type] => utility [patent_app_number] => 10/514302 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1081 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256035.pdf [firstpage_image] =>[orig_patent_app_number] => 10514302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7448402 [patent_doc_number] => 20040009902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'CTP extended erythropoietin' [patent_app_type] => new [patent_app_number] => 10/438277 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1099 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20040009902.pdf [firstpage_image] =>[orig_patent_app_number] => 10438277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297180 [patent_doc_number] => 20040214748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Hemoglobin conjugates' [patent_app_type] => new [patent_app_number] => 10/420966 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2306 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214748.pdf [firstpage_image] =>[orig_patent_app_number] => 10420966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7397964 [patent_doc_number] => 20040018560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Crystallized LXR polypeptide in complex with a ligand and screening methods employing same' [patent_app_type] => new [patent_app_number] => 10/418007 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 181580 [patent_no_of_claims] => 105 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018560.pdf [firstpage_image] =>[orig_patent_app_number] => 10418007 [rel_patent_id] =>[rel_patent_doc_number] =>)